All Articles

A comprehensive review of patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease

Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease

Metabolic dysfunction-associated steatotic liver disease: a key factor in hepatocellular carcinoma therapy response

Bariatric surgery in patients with obesity and end-stage heart failure with left ventricular assist devices: a brief guide

Obesity, kidney and metabolic bariatric surgery: a surgeon's narrative review

Immunotherapy for type 1 diabetes

Onion-skin type of periductular sclerosis in mice with genetic deletion of biliary kindlin-2 as tight junction stabilizer: a pilot experiment indicating a primary sclerosing cholangitis (PSC) phenotype

Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD)

Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM1

Copper and liver fibrosis in MASLD: the two-edged sword of copper deficiency and toxicity

Role of skin enzymes in metabolism of topical drugs

Dysregulation of sphingolipid metabolism in liver fibrosis

From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction

Metabolic bariatric surgery, alcohol misuse and liver cirrhosis: a narrative review

Noninvasive testing in the diagnosis of metabolic dysfunction-associated steatohepatitis

Editorial - Reflecting on three years of M&TOD - Where we are and where we are going

Evaluation of weight loss and quality of life in long-term post-bariatric surgery

Prevention and control of risk factors in metabolic and alcohol-associated steatotic liver disease